Atlas Trials

A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes

Clinical trial NCT01624259 · COMPLETED

Trial details

NCT number
NCT01624259
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2012-06-01
Primary completion
2013-11-01
Enrollment
599

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.